Drug intelligence / Profile preview

L-709,587

Development stage: Unknown
Modality: Small Molecules

Overview

L-709,587 is a synthetic small molecule belonging to the class of macrolide lactams. It has been identified as an inhibitor of certain biological processes through the inhibition of enzymes or proteins. The compound's precise mechanism of action involves enzyme or protein inhibition, but specific targets are not detailed in public sources. Its chemical structure is cataloged under DrugBank ID DB03621 and PubChem Compound ID 5496872[1][2][3][4]. There is no evidence that it has reached advanced clinical development or approval for any indication.

Targets

ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on L-709,587.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-709,587.

Explore the full profile